The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients

[1]  D. Colombo,et al.  Cyclosporine and Herbal Supplement Interactions , 2014, Journal of toxicology.

[2]  Rosa Parisi,et al.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.

[3]  S. Klein,et al.  Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[4]  I. Spoletini,et al.  A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics. , 2011, Therapeutic delivery.

[5]  A. Francavilla,et al.  Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. , 2011, Gastroenterology.

[6]  R. Alaghehbandan,et al.  Adverse Drug Events in Adult Patients Leading to Emergency Department Visits , 2010, The Annals of pharmacotherapy.

[7]  E. Olshansky,et al.  Women's mental health: depression and anxiety. , 2009, The Nursing clinics of North America.

[8]  Josip Car,et al.  Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 , 2007, BMC clinical pharmacology.

[9]  V. Cuomo,et al.  Gender differences in drug responses. , 2007, Pharmacological research.

[10]  A. Holdcroft,et al.  Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females? , 2006, Pharmacoepidemiology and drug safety.

[11]  I. Heineck,et al.  Adverse drug reactions: a cohort study in internal medicine units at a university hospital , 2006, European Journal of Clinical Pharmacology.

[12]  G. Trifirò,et al.  Adverse drug events in emergency department population: a prospective Italian study , 2005, Pharmacoepidemiology and drug safety.

[13]  M. Anthony.  Male/female differences in pharmacology: safety issues with QT-prolonging drugs. , 2005, Journal of women's health.

[14]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[15]  M. Atkinson,et al.  Health and Quality of Life Outcomes , 2004 .

[16]  M. Cesari,et al.  Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) , 2002, Journal of the American Geriatrics Society.

[17]  A. W. Lenderink,et al.  Risk factors for the development of adverse drug events in hospitalized patients , 2000, Pharmacy World and Science.

[18]  F. Follath,et al.  Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. , 2000, British journal of clinical pharmacology.

[19]  R. Mann,et al.  Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. , 1998, British journal of clinical pharmacology.

[20]  S. Knowles,et al.  Gender Differences in Adverse Drug Reactions , 1998, Journal of clinical pharmacology.

[21]  A. Kashuba,et al.  Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of Drugs , 1998, Clinical pharmacokinetics.

[22]  S. Chimenti,et al.  Therapeutic approaches in psoriasis: a post-hoc analysis of the PSYCHAE study from a gender point of view , 2014 .

[23]  F. Franconi,et al.  Sex and gender in adverse drug events, addiction, and placebo. , 2012, Handbook of experimental pharmacology.

[24]  C. Pedone,et al.  Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population. , 2005, Archives of gerontology and geriatrics.

[25]  C. Naranjo,et al.  Sex-related variations in the frequency and characteristics of adverse drug reactions. , 1980, International journal of clinical pharmacology, therapy, and toxicology.